Keyphrases
Transforming Growth Factor-β
100%
Hepatocellular Carcinoma
74%
CD133
68%
Km23-1
66%
Receptor-interacting Protein Kinase 1 (RIPK1)
59%
Dynein Light Chain
59%
Liver Cancer Stem Cells
53%
C-Met
50%
Epithelial-to-mesenchymal Transition
50%
TGF-1
43%
Transforming Growth Factor Receptor
35%
Colorectal Cancer Cells
33%
TCF7L1
33%
TGF-β Receptor
33%
Tumor
32%
Tight Junction Barrier
31%
Phosphorylation
31%
Stem Cells
27%
Tumor-initiating Cells
26%
Dynein
25%
Tumor Initiation
24%
Mesenchymal Phenotype
24%
Tumor-initiating
24%
Inflammatory Bowel Disease
23%
Pten
23%
Mesenchymal Cells
22%
Growth Inhibition
22%
Smad2
21%
Tumor Progression
21%
Murine Liver
20%
Overexpression
20%
Mesenchymal Tumor
20%
Intestinal Tight Junction
20%
Tumor Invasion
19%
Mediated Growth
19%
Human Colon Carcinoma Cells
19%
C-Fos
19%
Tumor Formation
19%
Liver-specific
19%
Survival Mechanism
18%
CD45
18%
Transcriptome Analysis
18%
Light Chain
18%
Motor Protein
18%
Smad3
18%
Experimental Colitis
18%
Putative Drug Targets
18%
Pathway Activation
18%
Disease Severity
17%
Induced Apoptosis
17%
Biochemistry, Genetics and Molecular Biology
Dynein
72%
Transforming Growth Factor
66%
Light Chain
66%
Tumor Progression
43%
Cancer Stem Cell
39%
Cancer Cell
37%
Growth Factor Receptor
35%
Mesenchymal-Epithelial Transition
33%
Cancer Growth Factor
33%
CD133
33%
Hepatocyte Growth Factor
30%
Colon
29%
Carcinogenesis
27%
Gene Expression Profiling
27%
Small Interfering RNA
27%
Promoter Region
26%
CD44
25%
Signal Transduction
24%
Programmed Cell Death
24%
Tumor Initiation
23%
Cell Migration
22%
AP-1 Transcription Factor
20%
C-Fos
20%
Secretion (Process)
20%
Gene Expression
19%
Extracellular Signal-Regulated Kinases
19%
Stem Cell
18%
DNA Methyltransferase
18%
Growth Inhibition
18%
Motor Protein
18%
Epigenetics
18%
Molecular Motor
18%
Dynamics
18%
Stem Cell Marker
18%
Prometaphase
16%
Occludin
16%
Mitosis Inhibition
16%
Fibronectin
16%
LGR5
16%
Proton Pump
16%
Protein Modification
16%
Autoinduction
16%
Macromolecule
16%
Cell Motility
16%
Sonic Hedgehog
16%
Wnt Signaling Pathway
16%
CREB
16%
Transferase
16%
Hedgehog Signaling Pathway
16%
Mucin
16%
Medicine and Dentistry
Cancer Stem Cell
36%
Hepatocellular Carcinoma
35%
Liver Cancer
33%
Tumor Progression
31%
In Vitro
26%
Neoplasm
26%
Programmed Cell Death
25%
5 (2,6 Dichlorobenzylsulfonyl) 3 [3,5 Dimethyl 4 [2 (1 Pyrrolidinylmethyl) 1 Pyrrolidinylcarbonyl] 1h Pyrrol 2 Ylmethylene] 1,3 Dihydro 2h Indol 2 One
23%
Tumor Invasion
22%
Colon Carcinoma
22%
Inflammatory Bowel Disease
21%
Organoid
20%
Mitogen-Activated Protein Kinase
20%
Secretion (Process)
19%
Phosphatase
19%
Methionine Adenosyltransferase
18%
Ex Vivo
18%
Liver Stem Cell
18%
Scatter Factor
18%
Disease Severity
17%
Complex Formation
16%
Tight Junction
16%
Transforming Growth Factor
16%
Cancer Growth Factor
16%
Proton-Pump Inhibitor
16%
Experimental Colitis
16%
Epidermal Growth Factor Receptor
16%
Colorectal Carcinoma
16%
Histone Deacetylase Inhibitor
16%
Belinostat
16%
Cuprous Ion
16%
Immunity
16%
Chromosome 10
16%
Cell Motility
16%
Carcinoma Cell
16%
Prematurity
16%
Antineoplastic Activity
16%
Gene Expression
11%
Cell Signaling Pathway
11%
Metastatic Carcinoma
11%
Promoter Region
11%
Small Interfering RNA
10%
Cell Proliferation
10%
Cancer
10%
Cancer Growth
9%
Ulcerative Colitis
9%
Cholangiocyte
8%
Phosphatidylinositol 3,4,5 Trisphosphate 3 Phosphatase
8%
Progenitor Cell
8%
Crohn's Disease
7%
